Psoralen promotes SOCS5 to inhibit JAK/STAT3 to alleviate cartilage degeneration in knee osteoarthritis
Phytomedicine · 2026
DOI: 10.1016/j.phymed.2025.157643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Jiahao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China; The Fifth Clinical College of Guangzhou University of Chinese Medicine,…. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, STAT3 Transcription Factor, Ficusin. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Bureau, China Postdoctoral Science Foundation, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
BACKGROUND: Knee osteoarthritis (KOA) is a prevalent degenerative joint disease characterized by progressive cartilage destruction. Bushen Qiangjin Capsule (BSQJ) is a clinically used traditional medicine for KOA, yet its active ingredients and mechanisms of action remain unclear. PURPOSE: This study aimed to identify the key active ingredient in BSQJ and investigate its therapeutic target and mechanism against KOA. MATERIALS AND METHODS: We integrated bioinformatics analysis of GEO datasets with molecular docking to pinpoint key targets. The therapeutic effects of the identified compound, psoralen, were then validated in a rat model of KOA using micro-CT, gait analysis, and histological staining. The mechanism was further investigated in LPS-induced chondrocytes and via siRNA silencing. RESULTS: Bioinformatics analysis identified 13 upregulated proteins and 12 downregulated proteins in KOA and SOCS5 as a key diagnostic target for KOA. Psoralen, a primary active ingredient in BSQJ, exhibited strong binding to SOCS5. In KOA rats, psoralen treatment significantly improved gait abnormalities, reduced subchondral bone sclerosis, and promoted cartilage repair. In vitro, psoralen reversed the imbalance in extracellular matrix (ECM) synthesis and enhanced chondrocyte proliferation. Mechanistically, psoralen exerted its effects by upregulating SOCS5, thereby downregulating JAK and phosphorylation of STAT3. CONCLUSION: Our findings demonstrate that psoralen is a key therapeutic component of BSQJ for KOA treatment. It alleviates cartilage degeneration by targeting SOCS5 and modulating the JAK-STAT3 pathway, thereby restoring chondrocyte metabolic homeostasis. This study provides a pharmacological basis for psoralen as a promising candidate drug for KOA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China; The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510095, Guangdong, China; Guangdong Provincial Second Hospi…
- Shanghai University of Traditional Chinese Medicine, Shenzhen Hospital, Shenzhen 51800, Guangdong, China.
- Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China; The First Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China.
- Dongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan 523005, Guangdong, China. Electronic address: yxl20160228@163.com.
- Guangdong Provincial Second Hospital of Traditional Chinese Medicine (Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine), Guangzhou 510095, Guangdong, China; Guangdong Provin…
Förderung
- Guangzhou Municipal Science and Technology Bureau
- China Postdoctoral Science Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangzhou University of Chinese Medicine
- National Natural Science Foundation of China
- State Administration of Traditional Chinese Medicine of the People's Republic of China
Zitieren
APA
Zhang, J., Tian, J., Weiyang, W., Yang, Y., Li, Y., Ye, X., Huang, D., & Xu, X. (2026). Psoralen promotes SOCS5 to inhibit JAK/STAT3 to alleviate cartilage degeneration in knee osteoarthritis. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157643
Vancouver
Zhang J, Tian J, Weiyang W, Yang Y, Li Y, Ye X, et al. Psoralen promotes SOCS5 to inhibit JAK/STAT3 to alleviate cartilage degeneration in knee osteoarthritis. Phytomedicine. 2026. doi:10.1016/j.phymed.2025.157643
BibTeX
@article{Zhang2026,
author = {Zhang, Jiahao and Tian, Jiaqing and Weiyang, Wenxiang and Yang, Yunhong and Li, Yiyan and Ye, Xiangling and Huang, Dane and Xu, Xuemeng},
title = {Psoralen promotes SOCS5 to inhibit JAK/STAT3 to alleviate cartilage degeneration in knee osteoarthritis},
journal = {Phytomedicine},
year = {2026},
doi = {10.1016/j.phymed.2025.157643}
}
EUVIMED